| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S002800050060 |
| P698 | PubMed publication ID | 8281626 |
| P2093 | author name string | B T Hill | |
| L K Hosking | |||
| P2860 | cites work | Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells | Q34031806 |
| Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog | Q34560047 | ||
| Cyclosporins as drug resistance modifiers | Q35250358 | ||
| Effect of calcium antagonists on the chemosensitivity of two multidrug-resistant human tumour cell lines which do not overexpress P-glycoprotein | Q36466963 | ||
| Pharmacology of drugs that alter multidrug resistance in cancer | Q37969138 | ||
| Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy. | Q38014962 | ||
| Mechanism of multidrug resistance | Q39469004 | ||
| Photoaffinity labeling of P-glycoprotein in multidrug-resistant cells | Q40707964 | ||
| Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro | Q40922557 | ||
| Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas | Q41091016 | ||
| Adequate tumour quinidine levels for multidrug resistance modulation can be achieved in vivo | Q41129559 | ||
| Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. | Q41338544 | ||
| In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative | Q41610629 | ||
| Relationship of VP-16 to the classical multidrug resistance phenotype | Q41624105 | ||
| Synergistic interaction of cyclosporin A and verapamil on vincristine and daunorubicin resistance in multidrug-resistant human leukemia cells in vitro | Q41645738 | ||
| Combinedin vitro modulation of adriamycin resistance | Q41660613 | ||
| Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators | Q41678987 | ||
| In vitro and in vivo modulation of multi-drug resistance with amiodarone | Q41679060 | ||
| B-859-35, a new drug with anti-tumor activity reverses multi-drug resistance. | Q41689647 | ||
| Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model | Q41699684 | ||
| Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells | Q41727067 | ||
| Chemosensitisation by verapamil and cyclosporin A in mouse tumour cells expressing different levels of P-glycoprotein and CP22 (sorcin). | Q41729794 | ||
| Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. | Q41734147 | ||
| Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. | Q41913157 | ||
| Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells | Q41914787 | ||
| Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. | Q42249927 | ||
| Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies | Q42812351 | ||
| Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines | Q42818279 | ||
| Reversal of multidrug resistance by phenothiazines and structurally related compounds | Q44109141 | ||
| Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. | Q44598583 | ||
| Clinical trials of agents that reverse multidrug-resistance | Q44925627 | ||
| Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil | Q45178839 | ||
| CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA. | Q52828546 | ||
| Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26). | Q52828590 | ||
| Evaluation of S9788 as a potential modulator of drug resistance against human tumour sublines expressing differing resistance mechanisms in vitro. | Q54231073 | ||
| Enhancement of Cellular Accumulation of Cyclosporine by Anti-P-glycoprotein Monoclonal Antibody MRK-16 and Synergistic Modulation of Multidrug Resistance | Q54247396 | ||
| Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells. | Q54249661 | ||
| Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoprotein. | Q54252365 | ||
| Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON | Q54265673 | ||
| In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833 | Q54290439 | ||
| Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. | Q54340770 | ||
| Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs. | Q54420023 | ||
| Resistance to anthrapyrazoles and anthracyclines in multidrug-resistant P388 murine leukemia cells: reversal by calcium blockers and calmodulin antagonists. | Q54423441 | ||
| Verapamil hypersensitivity of vincristine resistant Chinese hamster ovary cell lines. | Q54428436 | ||
| Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. | Q54510017 | ||
| Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance | Q68183435 | ||
| Systemic toxic effects associated with high-dose verapamil infusion and chemotherapy administration | Q68184512 | ||
| P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil | Q68289591 | ||
| Multidrug-resistant myeloma: laboratory and clinical effects of verapamil as a chemosensitizer | Q68307412 | ||
| Expression of a multidrug resistance gene in human cancers | Q69366790 | ||
| Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus | Q69366904 | ||
| Multidrug resistance | Q69515477 | ||
| P-glycoprotein in human sarcoma: evidence for multidrug resistance | Q69904603 | ||
| Drug resistance in human lung cancer cell lines: cross-resistance studies and effects of the calcium transport blocker, verapamil | Q70148075 | ||
| Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells | Q70582896 | ||
| Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil | Q70721995 | ||
| P433 | issue | 4 | |
| P921 | main subject | multiple drug resistance | Q643839 |
| cytotoxicity | Q246181 | ||
| vinblastine | Q282629 | ||
| verapamil | Q410291 | ||
| P304 | page(s) | 317-324 | |
| P577 | publication date | 1994-01-01 | |
| P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
| P1476 | title | Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance. | |
| P478 | volume | 33 |
| Q35122459 | Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance. |
| Q41393111 | In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients |
| Q71216830 | Modulation of multidrug resistance with dexniguldipine hydrochloride (B8509-035) in the CC531 rat colon carcinoma model |
Search more.